U.S. Rep’s Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammograms

Note that some links may require registration or subscription.

An attorney for former Texas U.S. Rep. Eddie Bernice Johnson (D), who recently died at age 89 after developing an infection following back surgery, claimed her death was due to medical negligence. (AP)

The U.S. is in the midst another wave of COVID-19 as the JN.1 variant becomes dominant. (Washington Post)

During the first COVID-19 wave, an estimated 16,990 deaths in six countries may have been related to using hydroxychloroquine during hospitalization. (Biomedicine & Pharmacotherapy)

The FDA is investigating reports of alopecia, aspiration, and suicidal ideation in people taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). (CNN)

Robert F. Kennedy Jr. appointed a prominent anti-vaccine activist as his new presidential campaign communications director. (NBC News)

Mayo Clinic and Eli Lilly backed a startup from two Stanford Medicine physicians that created a voice-based artificial intelligence app to help manage medications like insulin, following a study published in JAMA Network Open last month. (Axios)

Regular hearing aid use cut the risk of death by 24% compared with people who had hearing loss but never used them. (The Lancet Healthy Longevity)

Ambulance workers at the border in Eagle Pass, Texas are struggling to keep up with the surge of migrants needing medical care. (New York Times)

Merck is looking to develop GLP-1 receptor agonist treatments that do more than just help with weight loss, the CEO said. (Reuters)

Meanwhile, Eli Lilly warned that its popular GLP-1 agent tirzepatide shouldn’t be used just for “cosmetic” weight loss. (The Hill)

U.S. counties with reduced broadband internet access were almost three times more likely to have no mental health physicians and no outpatient facilities. (Nature Mental Health)

The New Hampshire House passed a bill banning gender affirming surgeries for minors. (New Hampshire Bulletin)

Could a fingerprint test replace mammograms for breast cancer screenings? (Reuters)

A 4-year-old girl from Washington state died after overdosing on “rainbow fentanyl” pills belonging to her parents. (USA Today)

Exposure to more green space was linked with significantly higher bone mineral density in young kids. (JAMA Network Open)

A new lawsuit claimed an IVF embryo-growing solution made by the fertility technology company CooperSurgical was toxic and killed a couple’s embryos. (Reuters)

Just 92 seconds of transcranial magnetic stimulation helped boost patients’ ability to be hypnotized, allowing them to be treated with hypnosis-based therapy for fibromyalgia syndrome. (Nature Mental Health)

After months of negotiations, UnitedHealthcare is no longer in network with South Carolina’s Prisma Health. (Greenville News)

Please enable JavaScript to view the

comments powered by Disqus.